High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
There’s no risk. Start your trial today to see profiles of Delcath Systems (NASDAQ: DCTH) plus 5456 other startups.
Start Free 7 Day Trial Now